Hao Wang, PhD

Dr. Hao Wang is Associate Professor of Oncology at the Department of Oncology in the Johns Hopkins University School of Medicine. With a background as a biostatistician, she currently serves as the Director of the Biostatistics Shared Resource at the Sidney Kimmel Comprehensive Cancer Center of Johns Hopkins. Her research is centered around design of clinical trials and evaluation of biomarkers. 

Dr. Wang has more than 20 years of experience in the statistical design and analysis of biological, clinical and translational, and population studies in oncology. Her expertise and statistical leadership in immuno-oncology trial and precision oncology study design and analysis has played a pivotal role in establishing new clinical standards globally. One of Dr. Wang’s most notable work is her role as the lead statistician in a landmark trial that investigated the use of DNA mismatch repair as a genetic biomarker to select patients for immunotherapy using immune checkpoint blockade. This work resulted in the historical approval by the US FDA of a tumor-agnostic therapy. It changed standard of care in oncology treatments. 

Dr. Hao Wang received a bachelor’s degree in Chemistry from Wuhan University in China, and a Ph.D. in Biostatistics from the University of Pennsylvania School of Medicine.